Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 18 Apr 2017
At a glance
- Drugs Rabeprazole (Primary) ; Aspirin
- Indications Duodenal ulcer; Gastric ulcer
- Focus Adverse reactions
- Sponsors Eisai Co Ltd
- 11 Apr 2017 Planned End Date changed from 1 Mar 2018 to 1 Jun 2018.
- 11 Apr 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Oct 2017.
- 15 Dec 2016 Status changed from recruiting to active, no longer recruiting.